BRIGHT MINDS BIOSCIENCES INC
DRUG·10919W405·US·Common Stock·Healthcare - Biotechnology-Activist
DRUG (BRIGHT MINDS BIOSCIENCES INC) is held by 57 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($93.5M), BlackRock, Inc. ($45.4M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($36.2M). Net institutional sentiment: Bullish.
57
Holders
(2 Elite)
$324.4M
Total Value
76% (59)
Consensus
45 buying - 14 selling
13F: Insider & Congress:
Who's Trading
ActivistIMIan McDonald13.7%Jul 2, 2026
ActivistVPVestal Point Capital, LP5.0%May 15, 2026
ActivistVOVivo Opportunity Fund Holdings, L.P.5.2%May 12, 2026
ActivistCACormorant Asset Management, LP9.7%Apr 30, 2026
InsiderCLCormorant Asset Management, LPSell $9.8MApr 28, 2026
ActivistCOCommodore Capital LP0.3%Feb 17, 2026
ActivistPAPerceptive Advisors LLC4.6%Feb 17, 2026
ActivistADAdage Capital Management, L.P.5.6%Nov 13, 2025
ActivistSISio Capital Management, LLC2.7%Nov 12, 2025
Showing 1-20 of 61
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer